A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness

Clinical trial NCT00421304 · COMPLETED

Trial details

NCT number: NCT00421304
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

RSV Illness in ≤12 Months of Participants

Start date: 2007-01-10
Primary completion: 2009-09-17
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.